kilawattmusic.com • Professional Insights • Expert Commentary • Resource Center
kilawattmusic.com

gomesin peptide Quick Review,peptide

Unveiling the Power of Gomesin Peptide: A Spider's Defense Mechanism with Therapeutic Potential Gomesin induced necrotic cell deathand was cytotoxic to SH-SY5Y and PC12 cells. The peptide evoked a rapid and transient elevation of intracellular calcium 

gomesin peptide

gomesin peptide:Gomesin (Gm) is a cationic anti-microbial peptide

A
Anna Griffin

focuses 'gomesin peptide' on content structure and clarity and provides detailed analysis via Reddit and Facebook

Published on

Executive Summary

gomesin peptide Gomesin induced necrotic cell death Gomesin induced necrotic cell deathand was cytotoxic to SH-SY5Y and PC12 cells. The peptide evoked a rapid and transient elevation of intracellular calcium 

The intricate world of natural compounds continues to surprise us with its diverse and potent biological activities. Among these remarkable discoveries is the gomesin peptide, a fascinating molecule derived from the hemocytes of the Brazilian tarantula, *Acanthoscurria gomesiana*. This antimicrobial peptide (AMP), specifically gomesin (Gm), has garnered significant scientific interest due to its multifaceted properties, ranging from potent antimicrobial and antifungal effects to promising anticancer activities.

First isolated and characterized in the early 2000s, gomesin is an 18-residue peptide distinguished by its cysteine-rich structure, featuring four cysteine residues crucial for forming disulfide bridges. Its N-terminus is capped by a pyroglutamic acid, and its C-terminus is an Arg α-amide. This unique composition contributes to its stability and biological efficacy. The molecular mass of gomesin is approximately 2270.4 Da. Research has shown that gomesin exhibits a broad spectrum of activity against various microorganisms, including Gram-positive and Gram-negative bacteria, and fungi. This makes it a valuable subject of study in the ongoing search for novel therapeutic agents to combat the growing threat of antimicrobial resistance.

Beyond its direct antimicrobial action, gomesin peptide has demonstrated cell-autonomous antiproliferative and cytotoxic activities. Studies have indicated that gomesin induced necrotic cell death in certain cell lines, such as SH-SY5Y and PC12 cells, accompanied by a rapid and transient elevation of intracellular calcium. This cytotoxic potential has spurred investigations into its anticancer applications. Notably, gomesin has been found to selectively target and disrupt cancer cell membranes, offering a promising avenue for developing targeted cancer therapies. Furthermore, Gomesins (AgGom and HiGom) are therapeutically promising spider-derived peptides that exhibit potent cytotoxic activity against cancer cells, potentially via targeting specific phospholipid compositions.

The structural characteristics of gomesin have also been a focus of research. While the native gomesin peptide possesses significant bioactivity, scientists have explored modifications to enhance its stability and therapeutic profile. This has led to the development of synthesized backbone cyclized analogs of gomesin, such as cyclic gomesin (cGm). This cyclic gomesin, an 18-residue β-hairpin peptide containing two disulfide bonds and a cyclised backbone, demonstrates enhanced stability and potent activity, making it a stable redesigned spider peptide. These modified versions aim to improve drug delivery and efficacy in potential therapeutic applications.

The mechanism by which gomesin exerts its effects is also a subject of ongoing research. While some antimicrobial peptides are known to disrupt bacterial membranes by forming pores, evidence suggests that gomesin may operate through different pathways. For instance, research indicates that the peripheral antimicrobial peptide gomesin does not disrupt the bacterial membrane by forming stable transmembrane pores but rather induces lipid accumulation. This nuanced mechanism of action highlights the complexity and unique nature of this spider peptide.

The discovery of gomesin has paved the way for further exploration of similar molecules. Researchers have identified natural gomesin-like peptides that exhibit more selective antifungal activities compared to the original gomesin. This suggests a rich reservoir of potential therapeutic agents within the venom of spiders and other invertebrates. The study of gomesin and its analogs contributes to the broader field of peptides as emerging candidates for the prevention and treatment of various diseases.

In summary, the gomesin peptide represents a remarkable example of nature's ingenuity. As the first antimicrobial peptide (AMP) isolated from the hemocytes of a spider, it has opened new frontiers in the development of novel therapeutic strategies. Its potent antimicrobial, antifungal, and anticancer properties, coupled with ongoing research into its mechanisms of action and structural modifications, underscore its significant therapeutic potential. The continued investigation into this disulfide-rich host defense peptide promises exciting advancements in combating infectious diseases and cancer.

Related Articles

Frequently Asked Questions

Here are the most common questions about gomesin peptide.

by AH Benfield·2021·Cited by 35—Gomesin, a disulfide-rich host defense peptide expressed in the Brazilian spider Acanthoscurria gomesianaselectively targets and disrupts cancer cell membranes
Antimicrobialpeptidesoffer an alternative to conventional antimicrobials. Most antimicrobialpeptidesare cationic and amphiphilic and have a mechanism of 
by AH Benfield·2021·Cited by 35—Gomesin, a disulfide-rich host defense peptide expressed in the Brazilian spider Acanthoscurria gomesianaselectively targets and disrupts cancer cell membranes
by MA Fernandez-Rojo·2018·Cited by 23—In this study, we report thecell-autonomous antiproliferative and cytotoxic activitiesexhibited by the spider peptide gomesin (AgGom) and gomesin-like 

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More